Clopidogrel (Plavix)

Jules Comin, D. Kallmes

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

Clopidogrel is an inhibitor of platelet aggregation, indicated for the prevention of ischemic stroke and in-stent thrombosis. However, it has a number of drawbacks, including an increased risk of hemorrhage; a clinical effect that is slow in onset and irreversible; a genetically determined variability in its clinical potency; and interactions with other commonly administered drugs.

Original languageEnglish (US)
Pages (from-to)2002-2004
Number of pages3
JournalAmerican Journal of Neuroradiology
Volume32
Issue number11
DOIs
StatePublished - Dec 1 2011

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Clopidogrel (Plavix)'. Together they form a unique fingerprint.

  • Cite this